<DOC>
	<DOC>NCT01820884</DOC>
	<brief_summary>This randomized trial is studying the efficacy and safety of the hysterectomy alone compared with hysterectomy and bilateral salpingo-oophorectomy (BSO) for patients with Stage IA endometrial carcinoma.</brief_summary>
	<brief_title>The Safety of Ovarian Preservation in Stage IA Endometrial Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Endometrial Neoplasms</mesh_term>
	<criteria>FIGO stage: ⅠA, endometrial carcinoma; Female, Chinese women; premenopausal women； ≤ 50 years old; Pathological diagnosis by curettage/hysteroscopy : G1 No prior treatment; Provide written informed consent. The suspicious metastasis of ovarian; Family history of ovarian cancer; Suffering from other malignancies; Concurrently participating in other clinical trials; Unable or unwilling to sign informed consents; Unable or unwilling to abide by protocol.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2013</verification_date>
</DOC>